Ampersand collects $103m for latest fund

The healthcare-focused firm is seeking $300m for its Ampersand 2014 Limited Partnership.

Ampersand Capital has collected about $103 million for its Ampersand 2014 fund, according to documents filed with the US Securities and Exchange Commission.

The fund is seeking $300 million and is expected to close in the next six months, according to a source familiar with the matter. Ampersand declined to comment.

Atlantic-Pacific Capital and Harken Capital Securities are acting as placement agents for the fund, according to the SEC documents. Atlantic-Pacific declined to comment and Harken was unavailable at press time.

Ampersand typically invests between $10 million and $50 million in healthcare companies with between $10 million and $100 million of revenue. The firm’s prior fund, Ampersand 2011, held a final close on $175 million. Ampersand’s previous three funds have all raised between $175 million and $300 million.

Ampersand is based in Wellesley, Massachusetts and was founded in 1988 as a spin-out from brokerage firm PaineWebber, which is now owned by UBS. Founder and managing partner Richard Charpie led the spinout and leads the firm with managing partner Herbert Hooper, who joined in 2002.